The Pharmacological Activity of Camellia sinensis (L.) Kuntze on Metabolic and Endocrine Disorders: A Systematic Review

Impacto

Downloads

Downloads per month over past year

Sánchez-Paniagua López, Marta and González Burgos, Elena and Iglesias Peinado, Irene and Lozano Fernández, Rafael and Gómez-Serranillos Cuadrado, María Pilar (2020) The Pharmacological Activity of Camellia sinensis (L.) Kuntze on Metabolic and Endocrine Disorders: A Systematic Review. Biomolecules, 10 (4). p. 603. ISSN 2218-273X

[thumbnail of biomolecules-10-00603-v2.pdf] PDF
Creative Commons Attribution.

999kB

Official URL: https://doi.org/10.3390/biom10040603




Abstract

Tea made from Camellia sinensis leaves is one of the most consumed beverages worldwide. This systematic review aims to update Camellia sinensis pharmacological activity on metabolic and endocrine disorders. Inclusion criteria were preclinical and clinical studies of tea extracts and isolated compounds on osteoporosis, hypertension, diabetes, metabolic syndrome, hypercholesterolemia, and obesity written in English between 2014 and 2019 and published in Pubmed, Science Direct, and Scopus. From a total of 1384 studies, 80 reports met inclusion criteria. Most papers were published in 2015 (29.3%) and 2017 (20.6%), conducted in China (28.75%), US (12.5%), and South Korea (10%) and carried out with extracts (67.5%, especially green tea) and isolated compounds (41.25%, especially epigallocatechin gallate). Most pharmacological studies were in vitro and in vivo studies focused on diabetes and obesity. Clinical trials, although they have demonstrated promising results, are very limited. Future research should be aimed at providing more clinical evidence on less studied pathologies such as osteoporosis, hypertension, and metabolic syndrome. Given the close relationship among all endocrine disorders, it would be of interest to find a standard dose of tea or their bioactive constituents that would be beneficial for all of them.


Item Type:Article
Uncontrolled Keywords:Camellia sinensis; metabolic disorders; endocrine disorders; tea
Subjects:Medical sciences > Pharmacy > Diagnosis, laboratory
Medical sciences > Pharmacy > Pharmacology
Medical sciences > Pharmacy > Pharmaceutical chemistry
ID Code:67094
Deposited On:29 Jul 2021 14:36
Last Modified:17 Aug 2021 07:00

Origin of downloads

Repository Staff Only: item control page